(Q71763523)

English

A phase 2 study with epirubicin as second-line treatment of patients with advanced epithelial ovarian cancer

scientific article published on 01 November 1996

Statements

A phase 2 study with epirubicin as second-line treatment of patients with advanced epithelial ovarian cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit